Financial Health Report: Emerson Electric Co. (EMR)’s Ratios Tell a Tale

In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Emerson Electric Co. (NYSE: EMR) closed the day trading at $110.45 down -0.13% from the previous closing price of $110.59. In other words, the price has decreased by -$0.13 from its previous closing price. On the day, 2.08 million shares were traded. EMR stock price reached its highest trading level at $111.05 during the session, while it also had its lowest trading level at $109.87.

Ratios:

For a better understanding of EMR, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 27.53 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 53.38. For the most recent quarter (mrq), Quick Ratio is recorded 0.86 and its Current Ratio is at 1.16. In the meantime, Its Debt-to-Equity ratio is 0.52 whereas as Long-Term Debt/Eq ratio is at 0.37.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stephens on October 16, 2024, Downgraded its rating to Equal-Weight and sets its target price to $120 from $135 previously.

On September 06, 2024, Morgan Stanley started tracking the stock assigning a Underweight rating and target price of $105.

JP Morgan Downgraded its Overweight to Neutral on August 14, 2024, whereas the target price for the stock was revised from $132 to $115.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 04 ’24 when Piazza Nicholas J. sold 2,200 shares for $108.50 per share. The transaction valued at 238,700 led to the insider holds 22,754 shares of the business.

LEVATICH MATTHEW S sold 1,933 shares of EMR for $204,081 on Feb 15 ’24. The Director now owns 24,965 shares after completing the transaction at $105.58 per share. On Feb 14 ’24, another insider, Karsanbhai Surendralal Lanca, who serves as the President & CEO of the company, sold 2,344 shares for $106.02 each. As a result, the insider received 248,513 and left with 138,750 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EMR now has a Market Capitalization of 63177396224 and an Enterprise Value of 77534396416. As of this moment, Emerson’s Price-to-Earnings (P/E) ratio for their current fiscal year is 37.92, and their Forward P/E ratio for the next fiscal year is 18.67. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.81. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.73 while its Price-to-Book (P/B) ratio in mrq is 3.04. Its current Enterprise Value per Revenue stands at 4.571 whereas that against EBITDA is 17.65.

Stock Price History:

Over the past 52 weeks, EMR has reached a high of $119.53, while it has fallen to a 52-week low of $83.10. The 50-Day Moving Average of the stock is 4.68%, while the 200-Day Moving Average is calculated to be 2.93%.

Shares Statistics:

Over the past 3-months, EMR traded about 2.87M shares per day on average, while over the past 10 days, EMR traded about 2026270 shares per day. A total of 572.00M shares are outstanding, with a floating share count of 570.72M. Insiders hold about 0.35% of the company’s shares, while institutions hold 78.61% stake in the company. Shares short for EMR as of 1727654400 were 8755165 with a Short Ratio of 3.05, compared to 1724976000 on 7145624. Therefore, it implies a Short% of Shares Outstanding of 8755165 and a Short% of Float of 1.53.

Dividends & Splits

EMR’s forward annual dividend rate is 2.10, up from 2.095 a year ago. Against a Trailing Annual Dividend Yield of 0.018943848The stock’s 5-year Average Dividend Yield is 2.41.

Most Popular